Palliative RT research in prostate cancer: understanding the past, anticipating the future
Dennis, K.; Morgan, S.C.
Oncology 28(4): 313; 316
2014
ISSN/ISBN: 0890-9091 PMID: 24839803 Document Number: 677330
Document emailed within 1 workday
Related Documents
Chiarodo, A. 1991: National Cancer Institute roundtable on prostate cancer: future research directions Cancer Research 51(9): 2498-2505Salminen, E.K.; Sundström, J.; Nikkanen, V. 2006: Palliative chemotherapy with trofosfamide in advanced prostate cancer Anticancer Research 26(1b): 539-542
Leon, G.R.; Keel, P.K.; Klump, K.L.; Fulkerson, J.A. 1997: The future of risk factor research in understanding the etiology of eating disorders Psychopharmacology Bulletin 33(3): 405-411
Wolfe, J.; Klar, N.; Grier, H.E.; Duncan, J.; Salem-Schatz, S.; Emanuel, E.J.; Weeks, J.C. 2000: Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care JAMA 284(19): 2469-2475
Droller, M. 2006: Bladder cancer: understanding the disease and future implications for assessment and therapy Revue Medicale Suisse 2(90): 2776-2778; 2781-2782, 2784
Usami, M. 1998: Endocrine therapy for prostate cancer in the future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(6): 817-822
Ito, K. 2014: Screening for prostate cancer: present status and future perspectives Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2198-2203
Smith, J.A.; Scaletsky, R. 1993: Future directions in tumor marker technology for prostate cancer Urologic Clinics of North America 20(4): 771-777
Okihara, K. 2016: Current status and future perspective in Japanese prostate cancer screening Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl. 3: 275-279
Pandian, S.S.; Eremin, O.E.; McClinton, S.; Wahle, K.W.; Heys, S.D. 1999: Fatty acids and prostate cancer: current status and future challenges Journal of the Royal College of Surgeons of Edinburgh 44(6): 352-361
Smith, J.A. 1988: Hormonal therapy of prostate cancer: current concepts and future prospects Clinical Therapeutics 10(3): 281-286
Lewis, B.; Chalhoub, E.; Chalouhy, C.; Sartor, O. 2015: Radium-223 in Bone-Metastatic Prostate Cancer: Current Data and Future Prospects Oncology 29(7): 483-488
Milito, S.J.; Turrisi, A.T. 2000: Radiotherapy in prostate cancer: improvements in an effective treatment and future prospects of further gains Journal of the South Carolina Medical Association 96(2): 65-68
Mukaiyama, T. 1997: Cancer palliative medicine turning point in palliative oncology Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 776-784
Xu, Z.; Fu, Q.; Luo, X.; Lu, W. 2016: Does Surgical Bypass or Palliative Resections Offer the Better Palliative Treatment for Advanced Pancreatic Cancer? A Meta-Analysis American Surgeon 82(12): E346-E349
Maeno, A.; Habuchi, T. 2016: Current status of castration-resistant prostate cancer translational research Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 40-44
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Doherty, R.; Lubinski, J.; Manguoglu, E.; Luleci, G.; Christie, M.; Craven, P.; Bancroft, E.; Mitra, A.; Morgan, S.; Eeles, R. 2006: AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening Journal of BUON: Official Journal of the Balkan Union of Oncology 11(4): 415-418
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124